Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Public health decisions should rely on independent trials, not biased literature.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

MK-5108 is safe and shows potential against tumors, especially alone.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The treatment combination is effective and generally safe for lung cancer.

Extracellular vesicles are important for disease treatment and monitoring.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Monitoring for adverse effects in clinical treatments is crucial.